<DOC>
	<DOCNO>NCT02005744</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics CKD-501 patient impaired hepatic function compare normal hepatic function .</brief_summary>
	<brief_title>A Pharmacokinetic Study CKD-501 Patients With Impaired Hepatic Function</brief_title>
	<detailed_description>A Phase 1 , Non-randomized , Open , Parallel-Group study .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>A . Inclusion Criteria [ The subject impair hepatic function ] 1 . The subject 19 64 year old 2 . The subject stable hepatic disease impair hepatic function ChildPugh A B 3 . Body Weight ≥ 55kg 4 . If female , Negative pregnancy test screen pre dose Day 1 5 . The subject agree perform contraception study 6 . The subject agree write informed consent [ The subject normal hepatic function ] 1 . The subject 19 64 year old 2 . The subject match impaired hepatic function gender , age ( ± 5years ) body weight ( ± 10kg ) 3 . If female , Negative pregnancy test screen pre dose Day 1 4 . The subject agree perform contraception study 5 . The subject agree write informed consent B. exclusion criterion [ The subject impair hepatic function ] 1 . The subject impair hepatic function ChildPugh C 2 . The subject portosystemic shunt surgery 3 . The subject liver transplantation unsuitable study investigator 's judgement ( example , hepatic encephalopathy grade 3 4 , stroke , heart failure , cancer etc . ) The subject eligible participate chemotherapy radiofrequency ablation therapy within 6months ) 4 . The subject gastrointestinal disease surgery effect absorption Investigational product 5 . The subject take drug medicine effect metabolism Cytochrome P450 within 14days prior Day 1 6 . Positive antiHIV Ab venereal disease research laboratory etc . [ The subject normal hepatic function ] 1 . The subject liver disease abnormal Laboratory test ( Asparate transaminase &gt; 1.25 fold upper normal limit , Alanine transaminase &gt; 1.25 fold upper normal limit , Total bilirubin &gt; 1.5 fold upper normal limit ) 2 . The subject gastrointestinal disease surgery effect absorption Investigational product 3 . Estimated Glomerular filtration rate &lt; 60 mL/min/1.73m2 Modification Diet Renal Disease formula 4 . Positive HBsAg , antiHepatitis C virus Ab , antiHIV Ab venereal disease research laboratory 5 . The subject high blood pressure low blood pressure ( systolic blood pressure &gt; 150mmHg &lt; 100mmHg , diastolic blood pressure &gt; 90mmHg &lt; 60mmHg ) 6 . The subject take drug medicine effect metabolism Cytochrome P450 within 14days prior Day 1 etc .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>CKD-501</keyword>
</DOC>